NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Epigral Limited (NSE: EPIGRAL)
EPIGRAL Technical Analysis
3
As on 17th Jun 2025 EPIGRAL SHARE Price closed @ 1794.40 and we RECOMMEND Sell for LONG-TERM with Stoploss of 1889.81 & Sell for SHORT-TERM with Stoploss of 1830.36 we also expect STOCK to react on Following IMPORTANT LEVELS. |
EPIGRALSHARE Price
Open | 1825.00 | Change | Price | % |
High | 1839.00 | 1 Day | -21.50 | -1.18 |
Low | 1785.00 | 1 Week | -21.60 | -1.19 |
Close | 1794.40 | 1 Month | -42.10 | -2.29 |
Volume | 25869 | 1 Year | 459.25 | 34.40 |
52 Week High 2344.35 | 52 Week Low 895.35 |
NSE INDIA Most Active Stocks
IDEA | 6.60 | -1.35% |
KBCGLOBAL | 0.62 | 19.23% |
GTLINFRA | 1.81 | -2.69% |
STLTECH | 112.71 | 13.41% |
YESBANK | 19.94 | -1.48% |
RTNPOWER | 13.25 | -5.15% |
SUZLON | 64.52 | -1.36% |
JPPOWER | 17.41 | -1.58% |
ZEEL | 137.21 | -0.51% |
SEPC | 13.63 | 1.49% |
NSE INDIA Top Gainers Stocks
CINEVISTA | 21.34 | 19.96% |
KBCGLOBAL | 0.62 | 19.23% |
BIRLACABLE | 208.05 | 14.11% |
STLTECH | 112.71 | 13.41% |
KSHITIJPOL | 3.71 | 12.42% |
KSL | 904.50 | 12.00% |
KSL | 904.50 | 12.00% |
KSL | 904.50 | 12.00% |
RML | 1003.25 | 11.17% |
RML | 1003.25 | 11.17% |
NSE INDIA Top Losers Stocks
EPIGRAL Daily Charts |
EPIGRAL Intraday Charts |
Whats New @ Bazaartrend |
EPIGRAL Free Analysis |
|
EPIGRAL Important Levels Intraday
RESISTANCE | 1898.46 |
RESISTANCE | 1865.09 |
RESISTANCE | 1844.46 |
RESISTANCE | 1823.83 |
SUPPORT | 1764.97 |
SUPPORT | 1744.34 |
SUPPORT | 1723.71 |
SUPPORT | 1690.34 |
EPIGRAL Target June 2025
4th UP Target | 2633.76 |
3rd UP Target | 2345.59 |
2nd UP Target | 2167.46 |
1st UP Target | 1989.33 |
1st DOWN Target | 1481.07 |
2nd DOWN Target | 1302.94 |
3rd DOWN Target | 1124.81 |
4th DOWN Target | 836.64 |
EPIGRAL Weekly Target
4th UP Target | 2067.79 |
3rd UP Target | 1988.13 |
2nd UP Target | 1938.89 |
1st UP Target | 1889.65 |
1st DOWN Target | 1749.15 |
2nd DOWN Target | 1699.91 |
3rd DOWN Target | 1650.67 |
4th DOWN Target | 1571.01 |
EPIGRAL Target2025
4th UP Target | 4853.47 |
3rd UP Target | 3905.06 |
2nd UP Target | 3318.82 |
1st UP Target | 2732.58 |
1st DOWN Target | 1059.82 |
2nd DOWN Target | 473.58 |
3rd DOWN Target | -112.66 |
4th DOWN Target | -1061.07 |
Epigral Limited ( NSE INDIA Symbol : EPIGRAL )
Sector : N/A And Other Stocks in Same Sector
Sector : N/A And Other Stocks in Same Sector
EPIGRAL Synopsis Technicals View
50 Day EMA |
N/A (Short Term) |
N/A | |
100 Day EMA | N/A (Mid Term) | N/A | |
200 Day EMA | N/A (Long Term) | N/A | |
MACD (12 26 9) | N/A | N/A | |
RSI (14) | N/A | N/A | |
MFI (14) | N/A | N/A | |
CCI (20) | N/A | N/A | |
WILLIAM %R (14) | N/A | N/A | |
ADX (14) | N/A | N/A | |
PSAR | N/A | N/A | |
10 Day Avg Volume | N/A |
EPIGRAL Other Details
Segment | EQ | |
Market Capital | 0.00 | |
Sector | ||
Industry | ||
Offical website | > echo $website ; ?> |
EPIGRAL Address
![]() |
EPIGRAL Latest News
EPIGRAL Business Profile
N/A
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service